Research involving CJC-1295 (no DAC) and Ipamorelin centers on molecular-level analysis, including peptide sequence confirmation, receptor-binding modeling, solution stability assessment, and evaluation of peptide behavior within controlled analytical systems
Tendon-to-bone healing: Basic science aspects and enhancement techniques
A randomized, double-blind, placebo-controlled, dose escalation phase 1 clinical trial was conducted to assess the safety and tolerability of FAHF-2 in food allergy patients (2.2 g, 3.3 g, or 6.6 g, 3 times a day for 7 days)
Wolf et al., 2022
Drug discontinuation due to adverse events was slightly higher in the Wegovy group (6.1% vs 8%)
Research-grade drugs are largely relegated to laboratory use and are not suitable for human consumption